GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » LT-Debt-to-Total-Asset

Bioqual (Bioqual) LT-Debt-to-Total-Asset : 0.00 (As of May. 2018)


View and export this data going back to . Start your Free Trial

What is Bioqual LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bioqual's long-term debt to total assests ratio for the quarter that ended in May. 2018 was 0.00.

Bioqual's long-term debt to total assets ratio stayed the same from May. 2011 (0.00) to May. 2018 (0.00).


Bioqual LT-Debt-to-Total-Asset Historical Data

The historical data trend for Bioqual's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual LT-Debt-to-Total-Asset Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.01 -

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.01 -

Bioqual LT-Debt-to-Total-Asset Calculation

Bioqual's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in May. 2018 is calculated as

LT Debt to Total Assets (A: May. 2018 )=Long-Term Debt & Capital Lease Obligation (A: May. 2018 )/Total Assets (A: May. 2018 )
=0/26.305
=0.00

Bioqual's Long-Term Debt to Total Asset Ratio for the quarter that ended in May. 2018 is calculated as

LT Debt to Total Assets (Q: May. 2018 )=Long-Term Debt & Capital Lease Obligation (Q: May. 2018 )/Total Assets (Q: May. 2018 )
=0/26.305
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioqual  (OTCPK:BIOQ) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Bioqual LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Bioqual's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines